Russian Extreme Hypertriglyceridemia Registry (REGGI)
Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L), confirmed by at least two independent measurements.
• Written informed consent from the patient or legal guardian.
• No age restrictions.
Locations
Other Locations
Russian Federation
Astrakhan State Medical University
RECRUITING
Astrakhan
Chelyabinsk State Medical Academy
RECRUITING
Chelyabinsk
Kaluga City Clinical Hospital No. 5
RECRUITING
Kaluga
State Medical University
RECRUITING
Kazan'
National Medical Research Center of Cardiology Named after Academician E.I. Chazov
RECRUITING
Moscow
Research Centre for Medical Genetics
RECRUITING
Moscow
Contact Information
Primary
Marat Ezhov, MD, PhD
Marat_Ezhov@mail.ru
+7 495 414-6067
Backup
Uliana Chubykina, MD, PhD
uliankachubykina@gmail.com
+7 495 414-6067
Time Frame
Start Date: 2025-11-20
Estimated Completion Date: 2045-12
Participants
Target number of participants: 500
Treatments
Extreme Hypertriglyceridemia
Patients with triglyceride levels ≥10 mmol/L, confirmed by at least two independent measurements, under the care of participating lipid centers in the Russian Federation.
Related Therapeutic Areas
Sponsors
Collaborators: Research Centre for Medical Genetics, Russian Federation
Leads: Russian Cardiology Research and Production Center